{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T16:55:53Z","timestamp":1788454553031,"version":"build-2803163510"},"reference-count":67,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,19]],"date-time":"2025-08-19T00:00:00Z","timestamp":1755561600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000274","name":"British Heart Foundation","doi-asserted-by":"publisher","award":["PG\/21\/10557"],"award-info":[{"award-number":["PG\/21\/10557"]}],"id":[{"id":"10.13039\/501100000274","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000274","name":"British Heart Foundation","doi-asserted-by":"publisher","award":["PG\/23\/11680"],"award-info":[{"award-number":["PG\/23\/11680"]}],"id":[{"id":"10.13039\/501100000274","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.phrs.2025.107923","type":"journal-article","created":{"date-parts":[[2025,8,21]],"date-time":"2025-08-21T08:55:02Z","timestamp":1755766502000},"page":"107923","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Selective EPAC1 activators enhance endothelial function in models of vascular inflammation"],"prefix":"10.1016","volume":"220","author":[{"given":"Neil","family":"MacRitchie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danila","family":"Gurgone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jolanta","family":"Wiejak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graeme","family":"Barker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Burgoyne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Lezoualc\u2019h","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pasquale","family":"Maffia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9489-9253","authenticated-orcid":false,"given":"Stephen J.","family":"Yarwood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.phrs.2025.107923_bib1","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1038\/s41569-024-01007-z","article-title":"Tackling inflammation in atherosclerosis","volume":"21","author":"Shoaran","year":"2024","journal-title":"Nat. Rev. Cardiol."},{"issue":"3","key":"10.1016\/j.phrs.2025.107923_bib2","doi-asserted-by":"crossref","first-page":"179","DOI":"10.2174\/157340308785160570","article-title":"Roles of IL-6-gp130 signaling in vascular inflammation","volume":"4","author":"Hou","year":"2008","journal-title":"Curr. Cardiol. Rev."},{"issue":"6","key":"10.1016\/j.phrs.2025.107923_bib3","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1111\/j.1476-5381.2009.00612.x","article-title":"Statins suppress interleukin-6-induced monocyte chemo-attractant protein-1 by inhibiting janus kinase\/signal transducers and activators of transcription pathways in human vascular endothelial cells","volume":"159","author":"Jougasaki","year":"2010","journal-title":"Br. J. Pharm."},{"issue":"11","key":"10.1016\/j.phrs.2025.107923_bib4","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1038\/ncb874","article-title":"A novel Epac-specific cAMP analogue demonstrates independent regulation of Rap1 and ERK","volume":"4","author":"Enserink","year":"2002","journal-title":"Nat. Cell Biol."},{"issue":"6710","key":"10.1016\/j.phrs.2025.107923_bib5","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1038\/24884","article-title":"Epac is a Rap1 guanine-nucleotide-exchange factor directly activated by cyclic AMP","volume":"396","author":"de Rooij","year":"1998","journal-title":"Nature"},{"issue":"5397","key":"10.1016\/j.phrs.2025.107923_bib6","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1126\/science.282.5397.2275","article-title":"A family of cAMP-Binding proteins that directly activate Rap1","volume":"282","author":"Kawasaki","year":"1998","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.phrs.2025.107923_bib7","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1152\/physrev.00025.2017","article-title":"Intracellular cAMP sensor EPAC: physiology, pathophysiology, and therapeutics development","volume":"98","author":"Robichaux","year":"2018","journal-title":"Physiol. Rev."},{"issue":"10","key":"10.1016\/j.phrs.2025.107923_bib8","doi-asserted-by":"crossref","first-page":"5159","DOI":"10.1021\/acs.jmedchem.9b02094","article-title":"Synthesis and biochemical evaluation of noncyclic nucleotide exchange proteins directly activated by cAMP 1 (EPAC1) regulators","volume":"63","author":"Wang","year":"2020","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.phrs.2025.107923_bib9","doi-asserted-by":"crossref","first-page":"16505","DOI":"10.1038\/s41598-022-20607-8","article-title":"Protein interaction, cytotoxic, transcriptomic and proteomic responses to structurally distinct EPAC1 activators in HUVECs","volume":"12","author":"Wiejak","year":"2022","journal-title":"Sci. Rep."},{"issue":"10","key":"10.1016\/j.phrs.2025.107923_bib10","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.3390\/cells8101253","article-title":"Genome-Wide mapping defines a role for C\/EBP\u03b2 and c-Jun in Non-Canonical cyclic AMP signalling","volume":"8","author":"Wiejak","year":"2019","journal-title":"Cells"},{"issue":"2","key":"10.1016\/j.phrs.2025.107923_bib11","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.bbamcr.2018.11.004","article-title":"The novel exchange protein activated by cyclic AMP 1 (EPAC1) agonist, I942, regulates inflammatory gene expression in human umbilical vascular endothelial cells (HUVECs)","volume":"1866","author":"Wiejak","year":"2019","journal-title":"Biochim. Et. Biophys. Acta Mol. Cell Res."},{"issue":"11","key":"10.1016\/j.phrs.2025.107923_bib12","doi-asserted-by":"crossref","first-page":"6843","DOI":"10.1074\/jbc.M710342200","article-title":"Identification of CCAAT\/Enhancer-binding proteins as exchange protein activated by cAMP-activated transcription factors that mediate the induction of the SOCS-3 Gene*","volume":"283","author":"Yarwood","year":"2008","journal-title":"J. Biol. Chem."},{"issue":"6","key":"10.1016\/j.phrs.2025.107923_bib13","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1172\/JCI64784","article-title":"Epac1-dependent phospholamban phosphorylation mediates the cardiac response to stresses","volume":"124","author":"Okumura","year":"2014","journal-title":"J. Clin. Invest"},{"issue":"4","key":"10.1016\/j.phrs.2025.107923_bib14","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1189\/jlb.0709513","article-title":"A2A adenosine receptor stimulation decreases foam cell formation by enhancing ABCA1-dependent cholesterol efflux","volume":"87","author":"Bingham","year":"2010","journal-title":"J. Leukoc. Biol."},{"issue":"12","key":"10.1016\/j.phrs.2025.107923_bib15","doi-asserted-by":"crossref","DOI":"10.1161\/ATVBAHA.119.314238","article-title":"Epac1 (Exchange Protein Directly Activated by cAMP 1) upregulates LOX-1 (Oxidized Low-Density Lipoprotein Receptor 1) to promote foam cell formation and atherosclerosis development","volume":"40","author":"Robichaux","year":"2020","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"7","key":"10.1016\/j.phrs.2025.107923_bib16","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1210\/me.2014-1330","article-title":"Rp-cAMPS prodrugs reveal the cAMP dependence of First-Phase Glucose-Stimulated insulin secretion","volume":"29","author":"Schwede","year":"2015","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.phrs.2025.107923_bib17","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.yjmcc.2015.01.015","article-title":"PDE4 inhibition reduces neointima formation and inhibits VCAM-1 expression and histone methylation in an Epac-dependent manner","volume":"81","author":"Lehrke","year":"2015","journal-title":"J. Mol. Cell Cardiol."},{"issue":"4","key":"10.1016\/j.phrs.2025.107923_bib18","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1093\/cvr\/cvv176","article-title":"The cAMP-producing agonist beraprost inhibits human vascular smooth muscle cell migration via exchange protein directly activated by cAMP","volume":"107","author":"McKean","year":"2015","journal-title":"Cardiovasc Res."},{"issue":"6","key":"10.1016\/j.phrs.2025.107923_bib19","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1016\/j.cellsig.2009.01.038","article-title":"Forskolin increases angiogenesis through the coordinated cross-talk of PKA-dependent VEGF expression and Epac-mediated PI3K\/Akt\/eNOS signaling","volume":"21","author":"Namkoong","year":"2009","journal-title":"Cell Signal"},{"issue":"1","key":"10.1016\/j.phrs.2025.107923_bib20","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.1002038","article-title":"Structure-guided design of selective Epac1 and Epac2 agonists","volume":"13","author":"Schwede","year":"2015","journal-title":"PLoS Biol."},{"issue":"2","key":"10.1016\/j.phrs.2025.107923_bib21","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/s00424-008-0508-3","article-title":"Epac activation, altered calcium homeostasis and ventricular arrhythmogenesis in the murine heart","volume":"457","author":"Hothi","year":"2008","journal-title":"Pflug. Arch. Eur. J. Physiol."},{"issue":"5","key":"10.1016\/j.phrs.2025.107923_bib22","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1042\/BST20190254","article-title":"Selective small-molecule EPAC activators","volume":"47","author":"Luchowska-Sta\u0144ska","year":"2019","journal-title":"Biochem. Soc. Trans."},{"issue":"1","key":"10.1016\/j.phrs.2025.107923_bib23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-017-00455-7","article-title":"Identification of a novel, small molecule partial agonist for the cyclic AMP sensor, EPAC1","volume":"7","author":"Parnell","year":"2017","journal-title":"Sci. Rep."},{"issue":"11","key":"10.1016\/j.phrs.2025.107923_bib24","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.3390\/cells8111425","article-title":"Identification of a novel class of benzofuran oxoacetic acid-derived ligands that selectively activate cellular EPAC1","volume":"8","author":"Beck","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.phrs.2025.107923_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2024.111444","article-title":"Non-cyclic nucleotide EPAC1 activators suppress lipopolysaccharide-regulated gene expression, signalling and intracellular communication in differentiated macrophage-like THP-1 cells","volume":"124","author":"Wiejak","year":"2024","journal-title":"Cell Signal"},{"issue":"1","key":"10.1016\/j.phrs.2025.107923_bib26","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1093\/cvr\/cvu242","article-title":"F. Lezoualc'h, exchange protein directly activated by cAMP 1 promotes autophagy during cardiomyocyte hypertrophy","volume":"105","author":"Laurent","year":"2015","journal-title":"Cardiovasc Res."},{"key":"10.1016\/j.phrs.2025.107923_bib27","doi-asserted-by":"crossref","first-page":"849","DOI":"10.3389\/fimmu.2019.00849","article-title":"A novel Triple-Cell Two-Dimensional model to study Immune-Vascular interplay in atherosclerosis","volume":"10","author":"Noonan","year":"2019","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.phrs.2025.107923_bib28","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-43221-8","article-title":"Vascular smooth muscle cells enhance immune\/vascular interplay in a 3-cell model of vascular inflammation","volume":"13","author":"Wiejak","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.phrs.2025.107923_bib29","doi-asserted-by":"crossref","unstructured":"W. Gu, Z. Ni, Y.Q. Tan, J. Deng, S.J. Zhang, Z.C. Lv, X.J. Wang, T. Chen, Z. Zhang, Y. Hu, Z.C. Jing, Q. XuAdventitial Cell Atlas of wt (Wild Type) and ApoE (Apolipoprotein E)-Deficient Mice Defined by Single-Cell RNA Sequencing, Arterioscler Thromb Vasc Biol 39(6) (2019) 1055-1071..","DOI":"10.1161\/ATVBAHA.119.312399"},{"issue":"3","key":"10.1016\/j.phrs.2025.107923_bib30","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0173085","article-title":"Activation of g protein-coupled estrogen receptor 1 induces coronary artery relaxation via Epac\/Rap1-mediated inhibition of RhoA\/Rho kinase pathway in parallel with PKA","volume":"12","author":"Yu","year":"2017","journal-title":"PLoS One"},{"issue":"11","key":"10.1016\/j.phrs.2025.107923_bib31","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1167\/iovs.64.11.34","article-title":"Upregulation of Epac1 promotes pericyte loss by inducing mitochondrial fission, reactive oxygen species production, and apoptosis","volume":"64","author":"Yang","year":"2023","journal-title":"Invest Ophthalmol. Vis. Sci."},{"issue":"12","key":"10.1016\/j.phrs.2025.107923_bib32","doi-asserted-by":"crossref","first-page":"2617","DOI":"10.1161\/ATVBAHA.115.306534","article-title":"Epac1 deficiency attenuated vascular smooth muscle cell migration and neointimal formation","volume":"35","author":"Kato","year":"2015","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"8","key":"10.1016\/j.phrs.2025.107923_bib33","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1038\/s41591-019-0512-5","article-title":"Atheroprotective roles of smooth muscle cell phenotypic modulation and the TCF21 disease gene as revealed by single-cell analysis","volume":"25","author":"Wirka","year":"2019","journal-title":"Nat. Med."},{"issue":"12","key":"10.1016\/j.phrs.2025.107923_bib34","doi-asserted-by":"crossref","first-page":"2576","DOI":"10.1161\/ATVBAHA.107.153080","article-title":"IL-6 deficiency protects against angiotensin II induced endothelial dysfunction and hypertrophy","volume":"27","author":"Schrader","year":"2007","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"4","key":"10.1016\/j.phrs.2025.107923_bib35","doi-asserted-by":"crossref","first-page":"C554","DOI":"10.1152\/ajpcell.00323.2020","article-title":"Overlapping and distinct biological effects of IL-6 classic and trans-signaling in vascular endothelial cells","volume":"320","author":"Montgomery","year":"2021","journal-title":"Am. J. Physiol. Cell Physiol."},{"issue":"10","key":"10.1016\/j.phrs.2025.107923_bib36","doi-asserted-by":"crossref","first-page":"4113","DOI":"10.1111\/j.1582-4934.2009.00891.x","article-title":"The aortic ring model of angiogenesis: a quarter century of search and discovery","volume":"13","author":"Nicosia","year":"2009","journal-title":"J. Cell Mol. Med."},{"issue":"1","key":"10.1016\/j.phrs.2025.107923_bib37","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1186\/s13287-017-0631-1","article-title":"Angiogenic potency evaluation of cell therapy candidates by a novel application of the in vitro aortic ring assay","volume":"8","author":"Iqbal","year":"2017","journal-title":"Stem Cell Res Ther."},{"issue":"1","key":"10.1016\/j.phrs.2025.107923_bib38","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/nprot.2011.435","article-title":"Use of the mouse aortic ring assay to study angiogenesis","volume":"7","author":"Baker","year":"2011","journal-title":"Nat. Protoc."},{"issue":"12","key":"10.1016\/j.phrs.2025.107923_bib39","doi-asserted-by":"crossref","first-page":"2563","DOI":"10.3390\/ijms18122563","article-title":"Cellular and oxidative mechanisms associated with Interleukin-6 signaling in the vasculature","volume":"18","author":"Didion","year":"2017","journal-title":"Int. J. Mol. Sci."},{"issue":"7","key":"10.1016\/j.phrs.2025.107923_bib40","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1038\/s12276-021-00649-0","article-title":"Interplay between interleukin-6 signaling and the vascular endothelium in cytokine storms","volume":"53","author":"Kang","year":"2021","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.phrs.2025.107923_bib41","article-title":"Single cell portal: an interactive home for single-cell genomics data","author":"Tarhan","year":"2023","journal-title":"bioRxiv"},{"issue":"7","key":"10.1016\/j.phrs.2025.107923_bib42","article-title":"A simplified aortic ring assay: a useful ex vivo method to assess biochemical and functional parameters of angiogenesis","volume":"6","author":"Kapoor","year":"2020","journal-title":"Matrix Biol."},{"issue":"3","key":"10.1016\/j.phrs.2025.107923_bib43","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1023\/B:AGEN.0000021397.18713.9c","article-title":"The mouse aorta model: influence of genetic background and aging on bFGF- and VEGF-induced angiogenic sprouting","volume":"6","author":"Zhu","year":"2003","journal-title":"Angiogenesis"},{"issue":"4","key":"10.1016\/j.phrs.2025.107923_bib44","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.niox.2006.03.011","article-title":"Nitric oxide and atherosclerosis: an update","volume":"15","author":"Napoli","year":"2006","journal-title":"Nitric Oxide"},{"issue":"8","key":"10.1016\/j.phrs.2025.107923_bib45","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1161\/ATVBAHA.109.190215","article-title":"How we learned to say NO","volume":"29","author":"Vanhoutte","year":"2009","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.phrs.2025.107923_bib46","doi-asserted-by":"crossref","first-page":"9344","DOI":"10.1038\/srep09344","article-title":"Biochemical and pharmacological characterizations of ESI-09 based EPAC inhibitors: defining the ESI-09 \"therapeutic window\"","volume":"5","author":"Zhu","year":"2015","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.phrs.2025.107923_bib47","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.vph.2014.01.004","article-title":"PKA and epac activation mediates cAMP-induced vasorelaxation by increasing endothelial NO production","volume":"60","author":"Garcia-Morales","year":"2014","journal-title":"Vasc. Pharm."},{"issue":"3","key":"10.1016\/j.phrs.2025.107923_bib48","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/S1734-1140(12)70846-0","article-title":"L-NAME in the cardiovascular system - nitric oxide synthase activator?","volume":"64","author":"Kopincova","year":"2012","journal-title":"Pharm. Rep."},{"issue":"14","key":"10.1016\/j.phrs.2025.107923_bib49","doi-asserted-by":"crossref","first-page":"5160","DOI":"10.3390\/ijms21145160","article-title":"EPAC in vascular smooth muscle cells","volume":"21","author":"Wehbe","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.phrs.2025.107923_bib50","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1007\/s00210-008-0334-3","article-title":"Role of Epac1 in mediating anti-proliferative effects of prostanoid EP(2) receptors and cAMP in human lung fibroblasts","volume":"378","author":"Haag","year":"2008","journal-title":"Naunyn Schmiede Arch. Pharm."},{"issue":"7","key":"10.1016\/j.phrs.2025.107923_bib51","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1093\/eurheartj\/ehr304","article-title":"Nitric oxide synthases: regulation and function","volume":"33","author":"F\u00f6rstermann","year":"2012","journal-title":"Eur. Heart J."},{"issue":"17","key":"10.1016\/j.phrs.2025.107923_bib52","doi-asserted-by":"crossref","first-page":"6333","DOI":"10.1128\/MCB.00207-06","article-title":"Exchange protein activated by cyclic AMP (Epac)-mediated induction of suppressor of cytokine signaling 3 (SOCS-3) in vascular endothelial cells","volume":"26","author":"Sands","year":"2006","journal-title":"Mol. Cell. Biol."},{"issue":"10","key":"10.1016\/j.phrs.2025.107923_bib53","doi-asserted-by":"crossref","first-page":"2170","DOI":"10.3390\/cells9102170","article-title":"Epac1 is crucial for maintenance of endothelial barrier function through a mechanism partly independent of Rac1","volume":"9","author":"Garc\u00eda-Ponce","year":"2020","journal-title":"Cells"},{"issue":"3","key":"10.1016\/j.phrs.2025.107923_bib54","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1091\/mbc.e06-10-0972","article-title":"Role of Epac1, an exchange factor for rap GTPases, in endothelial microtubule dynamics and barrier function","volume":"19","author":"Sehrawat","year":"2008","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.phrs.2025.107923_bib55","first-page":"3809092","article-title":"Epac1 restores normal insulin signaling through a reduction in inflammatory cytokines","author":"Curtiss","year":"2018","journal-title":"Mediat. Inflamm."},{"issue":"2","key":"10.1016\/j.phrs.2025.107923_bib56","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1074\/jbc.M117.815381","article-title":"The EPAC-Rap1 pathway prevents and reverses cytokine-induced retinal vascular permeability","volume":"293","author":"Ramos","year":"2018","journal-title":"J. Biol. Chem."},{"issue":"29","key":"10.1016\/j.phrs.2025.107923_bib57","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1093\/eurheartj\/ehad304","article-title":"Novel mechanisms and therapeutic targets in atherosclerosis: inflammation and beyond","volume":"44","author":"Weber","year":"2023","journal-title":"Eur. Heart J."},{"issue":"1","key":"10.1016\/j.phrs.2025.107923_bib58","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1038\/s41569-020-0431-7","article-title":"Ageing and atherosclerosis: vascular intrinsic and extrinsic factors and potential role of IL-6","volume":"18","author":"Tyrrell","year":"2021","journal-title":"Nat. Rev. Cardiol."},{"issue":"4","key":"10.1016\/j.phrs.2025.107923_bib59","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1161\/CIRCRESAHA.115.306301","article-title":"Endothelial cell dysfunction and the pathobiology of atherosclerosis","volume":"118","author":"Gimbrone","year":"2016","journal-title":"Circ. Res."},{"issue":"11","key":"10.1016\/j.phrs.2025.107923_bib60","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1161\/CIRCRESAHA.121.319077","article-title":"Interleukin-6 signaling and Anti-Interleukin-6 therapeutics in cardiovascular disease","volume":"128","author":"Ridker","year":"2021","journal-title":"Circ. Res."},{"key":"10.1016\/j.phrs.2025.107923_bib61","doi-asserted-by":"crossref","first-page":"152","DOI":"10.2174\/1874312901812010152","article-title":"Tocilizumab in large vessel vasculitis - different routes of administration","volume":"12","author":"Schmalzing","year":"2018","journal-title":"Open Rheuma J."},{"issue":"3","key":"10.1016\/j.phrs.2025.107923_bib62","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2023.103275","article-title":"The effectiveness of tocilizumab and its comparison with tumor necrosis factor alpha inhibitors for takayasu arteritis: a systematic review and meta-analysis","volume":"22","author":"Misra","year":"2023","journal-title":"Autoimmun. Rev."},{"issue":"1","key":"10.1016\/j.phrs.2025.107923_bib63","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1093\/rheumatology\/kead215","article-title":"Treatment of giant cell arteritis with ultra-short glucocorticoids and tocilizumab: the role of imaging in a prospective observational study","volume":"63","author":"Muratore","year":"2023","journal-title":"Rheumatology"},{"issue":"40","key":"10.1016\/j.phrs.2025.107923_bib64","doi-asserted-by":"crossref","first-page":"30057","DOI":"10.1074\/jbc.M606279200","article-title":"Stat3 mediates interleukin-6 [correction of interelukin-6] inhibition of human endothelial nitric-oxide synthase expression","volume":"281","author":"Saura","year":"2006","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.phrs.2025.107923_bib65","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1172\/JCI10373","article-title":"NF-kappaB: pivotal mediator or innocent bystander in atherogenesis?","volume":"107","author":"Collins","year":"2001","journal-title":"J. Clin. Invest"},{"issue":"6","key":"10.1016\/j.phrs.2025.107923_bib66","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1038\/nrcardio.2009.57","article-title":"Role for TNF in atherosclerosis? Lessons from autoimmune disease","volume":"6","author":"McKellar","year":"2009","journal-title":"Nat. Rev. Cardiol."},{"issue":"11","key":"10.1016\/j.phrs.2025.107923_bib67","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.1161\/ATVBAHA.107.149179","article-title":"Vascular adhesion molecules in atherosclerosis","volume":"27","author":"Galkina","year":"2007","journal-title":"Arterioscler. Thromb. Vasc. Biol."}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661825003482?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661825003482?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T10:47:00Z","timestamp":1772880420000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043661825003482"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":67,"alternative-id":["S1043661825003482"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2025.107923","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Selective EPAC1 activators enhance endothelial function in models of vascular inflammation","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2025.107923","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"107923"}}